Glucocorticoid Replacement for Adrenal Insufficiency and the Development of Non-Alcoholic Fatty Liver Disease

Glucocorticoid excess is a known risk factor for non-alcoholic fatty liver disease (NAFLD). Our objective was to analyse the impact of glucocorticoid replacement therapy on the development of NAFLD and NAFLD-related fibrosis and, therefore, on cardiovascular as well as hepatic morbidity in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Gesine, Gruendl, Madeleine, Chifu, Irina, Hahner, Stefanie, Werner, Johanna, Weiß, Johannes, Kienitz, Tina, Quinkler, Marcus, Badenhoop, Klaus, Herrmann, Eva, Friedrich-Rust, Mireen, Bojunga, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573835/
https://www.ncbi.nlm.nih.gov/pubmed/37835036
http://dx.doi.org/10.3390/jcm12196392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573835/
https://www.ncbi.nlm.nih.gov/pubmed/37835036
http://dx.doi.org/10.3390/jcm12196392

Ejemplares similares